Can hypothyroidism or celiac disease cause an isolated elevation of alanine aminotransferase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Hypothyroidism or Celiac Disease Cause Isolated Elevated ALT?

Yes, both hypothyroidism and celiac disease can cause isolated ALT elevation, though celiac disease does so more frequently and predictably than hypothyroidism.

Celiac Disease and ALT Elevation

Celiac disease is a well-established cause of isolated hypertransaminasemia that normalizes with gluten-free diet in the majority of patients. 1, 2

Prevalence and Pattern

  • Approximately 40% of untreated celiac disease patients demonstrate elevated AST and/or ALT levels prior to initiating a gluten-free diet, though more recent studies from high-prevalence areas report lower rates (11% with elevated AST). 1, 2
  • The elevation is typically mild (<5× upper limit of normal) and often occurs in patients with minimal or atypical gastrointestinal symptoms. 2
  • ALT elevation in celiac disease correlates significantly with intestinal permeability (a marker of small bowel damage), with higher permeability indices seen in patients with elevated transaminases (P < 0.0001). 1

Response to Treatment

  • Within 1 year of strict gluten-free diet, ALT and AST normalize in approximately 95% of celiac patients with initial elevation. 1
  • Even in celiac patients with initially normal transaminase levels, a significant decrease occurs on gluten-free diet, demonstrating gluten-dependent hepatocyte stress. 2
  • Gluten challenge in treated celiac patients in remission leads to mild and transient hypertransaminasemia, confirming the causal relationship. 2

Histologic Findings

  • When liver biopsy is performed in celiac patients with hypertransaminasemia, findings typically include mild to moderate hepatitis with septal fibrosis or minimal lymphocytic infiltrates of portal tracts, without inflammatory alterations of bile ducts. 1

Hypothyroidism and ALT Elevation

Hypothyroidism can cause elevation of liver enzymes, though AST elevation is more characteristic than isolated ALT elevation. 3

Pattern of Enzyme Abnormalities

  • Hypothyroidism is more commonly associated with AST elevation than ALT elevation. 3
  • Thyroid function tests (TSH and free T4) should be performed to rule out thyroid disorders as a cause of transaminase elevations. 4, 5
  • Thyroid diseases may be associated with elevation of alanine aminotransferase, though this is less specific than the AST elevation seen in hypothyroidism. 3

Clinical Context

  • The association between thyroid and liver diseases is well-established, particularly in autoimmune conditions (e.g., primary biliary cholangitis and hypothyroidism). 3
  • Measuring free T4 and TSH is recommended in patients with unexplained liver biochemical test abnormalities, as these remain normal in euthyroid patients with liver disease. 3

Diagnostic Approach for Isolated ALT Elevation

Initial Screening

  • Screen for celiac disease by measuring IgA tissue transglutaminase (tTG) antibodies with documentation of normal total serum IgA levels in all patients with unexplained ALT elevation. 6
  • Obtain thyroid function tests (TSH, free T4) as part of the initial evaluation for mildly elevated transaminases. 4, 5
  • A complete liver panel, including AST, ALT, alkaline phosphatase, total and direct bilirubin, albumin, and prothrombin time, should be performed. 4, 5

Risk Stratification

  • Celiac disease should be strongly considered in patients with metabolic syndrome or type 1 diabetes, as these populations have higher prevalence. 6
  • Autoimmune thyroid disease occurs in 17–30% of individuals with type 1 diabetes, making concurrent screening appropriate. 6

Follow-up and Monitoring

  • For mild ALT elevations (<2× ULN), repeat liver enzymes in 2–4 weeks to establish trend. 4
  • If celiac serology is positive, proceed to small bowel biopsy for confirmation before recommending lifelong gluten-free diet. 6
  • If thyroid dysfunction is identified, monitor ALT response to thyroid hormone replacement therapy. 3

Important Clinical Pitfalls

  • Do not assume isolated ALT elevation is benign without proper evaluation—up to 20.5% of apparently healthy individuals have ALT above normal range, suggesting underlying liver damage. 7
  • Do not overlook celiac disease in patients with minimal gastrointestinal symptoms—hypertransaminasemia may be the presenting feature in subclinical celiac disease. 2
  • Do not attribute persistent ALT elevation to non-alcoholic fatty liver disease without excluding celiac disease and hypothyroidism, as these are treatable causes that normalize with specific therapy. 1, 3
  • Normal ALT does not exclude significant liver disease—up to 50% of patients with celiac disease have normal liver chemistries despite ongoing intestinal damage. 4

References

Research

Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.

European journal of gastroenterology & hepatology, 1999

Research

Clinical associations between thyroid and liver diseases.

Journal of gastroenterology and hepatology, 1995

Guideline

Evaluation and Management of Mildly Elevated Transaminases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation and Management of Elevated Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevalence of elevated alanine aminotransferase levels in adult participants from a community-based study from northern part of India.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2020

Related Questions

How to manage a patient with hyperthyroidism, Vitamin B12 excess, leukocytosis, polycythemia, Vitamin D deficiency, mixed hyperlipidemia, metabolic acidosis, and liver enzyme elevation?
How should I evaluate and manage a 28-year-old man with an isolated elevation of alanine aminotransferase?
What is the management for a patient with hypertransaminasemia?
What is the appropriate management for a patient with hyperthyroidism, uncontrolled diabetes, and elevated liver enzymes?
What are the symptoms, causes, and management of various medical conditions including diabetes, kidney diseases, nutritional disorders, gastrointestinal issues, liver conditions, and thyroid disorders?
Is weight loss expected and safe in an adult woman with a history of chronic cocaine use who has been abstinent for one year and is currently receiving a GLP‑1 receptor agonist (e.g., semaglutide) for weight loss?
What does an FEV1/FVC ratio of 88.78% indicate in an adult?
How should I modify the diabetes and lipid therapy for a 64‑year‑old man with type 2 diabetes, hyperlipidemia, stage 3 chronic kidney disease, chronic heart failure, and compensated liver cirrhosis who now has an HbA1c of 9.2 % (up from 7.6 %) while taking dulaglutide (Trulicity) 3 mg weekly, glipizide (Glucotrol) XL 20 mg daily, and ezetimibe (Zetia) 10 mg daily, and who has mildly elevated transaminases, hypercholesterolemia, severe hypertriglyceridemia, and elevated LDL‑C?
Is diphenhydramine (Benadryl) effective for treating nausea?
What does a markedly low haptoglobin with elevated ferritin indicate and how should it be evaluated and managed?
In a healthy 55‑year‑old postmenopausal woman, are periorbital hyperpigmentation (dark under‑eye patches) a symptom of menopause?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.